The FDA is urging drug companies to pinpoint the cancer drug dosage that has the greatest impact with the fewest side effects. Its most recent study scrutinizes the dosage of a lung cancer drug, The Washington Post reported May 6.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
